The store will not work correctly when cookies are disabled.
(E)-6-(Diethylamino)-2-(4-hydroxy-3-methoxybenzylidene)-2,3-dihydro-1H-inden-1-one
ID: ALA4748399
Chembl Id: CHEMBL4748399
PubChem CID: 141532341
Max Phase: Preclinical
Molecular Formula: C21H23NO3
Molecular Weight: 337.42
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: CCN(CC)c1ccc2c(c1)C(=O)/C(=C/c1ccc(O)c(OC)c1)C2
Standard InChI: InChI=1S/C21H23NO3/c1-4-22(5-2)17-8-7-15-12-16(21(24)18(15)13-17)10-14-6-9-19(23)20(11-14)25-3/h6-11,13,23H,4-5,12H2,1-3H3/b16-10+
Standard InChI Key: IIIWABDJIQMXHU-MHWRWJLKSA-N
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 337.42 | Molecular Weight (Monoisotopic): 337.1678 | AlogP: 4.07 | #Rotatable Bonds: 5 |
Polar Surface Area: 49.77 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.48 | CX Basic pKa: 4.58 | CX LogP: 4.25 | CX LogD: 4.25 |
Aromatic Rings: 2 | Heavy Atoms: 25 | QED Weighted: 0.84 | Np Likeness Score: -0.10 |
References
1. Huo PC,Hu Q,Shu S,Zhou QH,He RJ,Hou J,Guan XQ,Tu DZ,Hou XD,Liu P,Zhang N,Liu ZG,Ge GB. (2021) Design, synthesis and biological evaluation of novel chalcone-like compounds as potent and reversible pancreatic lipase inhibitors., 29 [PMID:33214035] [10.1016/j.bmc.2020.115853] |
2. Huo PC,Guan XQ,Liu P,Song YQ,Sun MR,He RJ,Zou LW,Xue LJ,Shi JH,Zhang N,Liu ZG,Ge GB. (2021) Design, synthesis and biological evaluation of indanone-chalcone hybrids as potent and selective hCES2A inhibitors., 209 [PMID:33007602] [10.1016/j.ejmech.2020.112856] |